Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (9666)	6/4/2008 5:24:15 PM
From: IRWIN JAMES FRANKEL	Read Replies (6) of 10345

An update on my wife's experience on Tysabri since my post: From day 8-16 from the 4th infusion, the symptoms/disabilities continued to be greatly reduced. Starting about day 17 she noticed return of some of the symptoms which slowly became more noticeable through day 28. One symptom became fairly troubling by day 28. Even with the slow return of symptoms she was MUCH better off on day 28 than formerly. Yesterday morning, she received infusion #5. By evening she was feeling good, symptoms waned and the troubling one was gone almost entirely. At the doctors office prior to the infusion, she was tested (they do this every time) and they commented that she was stronger and walking much better. They described her experience as a "bonus" saying that they did not expect improvement and just hoped to slow the disease. Today, she has been working in the garden despite the heat (nearly 90F) and claims to be feeling very good. IMO - Tysabri is a modern miracle, at least for Karen. If Karen is typical of a significant class of MSRR patients, then Tysabri should become the standard of care. ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next